Lung Cancer (Non-Small Cell) Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Lung Cancer (Non-Small Cell)
Guangdong Association of Clinical Trials48 enrolled7 locationsNCT07198841
Recruiting
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
Lung Cancer (Non-Small Cell)Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences500 enrolled1 locationNCT07166003